medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2022; 20 (4)

Idiopathic chilblains. A case report

Zajdman FD, Armendáriz BY, Pérez CAE, Sáenz CCI, Toussaint CS, Vega MME
Full text How to cite this article

Language: Spanish
References: 17
Page: 415-419
PDF size: 245.42 Kb.


Key words:

perniosis, chilblains, covid-toes, acrocyanosis.

ABSTRACT

Perniosis or chilblains is an inflammatory skin disease caused by an inadequate vascular response to cold temperature. It presents as painful and pruritic erythro-violaceous lesions in acral sites. It can be primary (idiopathic perniosis) or secondary to an underlying disease such as connective tissue disorders, proliferative blood cell line disorders, sars-cov-2 infection, among others. The management of idiopathic perniosis consists of avoiding exposure to cold, and topical steroids if needed. We present a 59-year-old man, who presented with a three-month history of pruritic and painful erythematous-violaceous lesions on the palms and fingertips. The biopsy was compatible with perniosis, and diseases related to secondary perniosis were ruled out. Follow-up at four weeks showed complete resolution of lesions with conservative measures and topical steroids.


REFERENCES

  1. Corlett WT, Dermatitis hiemalis. A recurrent inflammation of theskin associated with cold weather, jama 1902; xxxxix(25):1583-8. Disponibleen: https://doi.org/10.1001/jama.1902.52480510023001e.

  2. Nyssen A, Benhadou F, Magnée M, André J, Koopmansch C y WautrechtJ, Chilblains, Vasa 2020; 49(2):133-40. Disponible en: https://doi.org/10.1024/0301-1526/a000838.

  3. Tobón MX y Rodríguez G, Eritema pernio: una enfermedad misteriosa,ces Medicina 2013; 27(1):113-26.

  4. Zaladonis A, Huang S y Hsu S, covid toes or pernio?, Clin Dermatol2020; 38(6):764-7. Disponible en: https://doi.org/10.1016/j.clindermatol.2020.06.002.

  5. Bielsa Marsol I, Perniosis, Semin Fund Esp Reumatol 2012; 13(2):55-61. Disponibleen: https://doi.org/10.1016/j.semreu.2011.12.003.

  6. Külcü Çakmak S, Gönül M, Og˘uz ID, Yayla D, Gül Ü y Köse K, Demographical,laboratory and associated findings in patients with perniosis,J Eur Acad Dermatol Venereol 2014; 28(7):891-4. Disponible en: https://doi.org/10.1111/jdv.12199.

  7. Cappel MA, Cappel JA y Wetter DA, Pernio (chilblains), sars-cov-2,and covid toes unified through cutaneous and systemic mechanisms,Mayo Clin Proc 2021; 96(4):989-1005. Disponible en: https://doi.org/10.1016/j.mayocp.2021.01.009.

  8. Takci Z, Vahaboglu G y Eksioglu H, Epidemiological patterns ofperniosis, and its association with systemic disorder, Clin Exp Dermatol2012; 37(8):844-9. Disponible en: https://doi.org/10.1111/j.1365-2230.2012.04435.x.

  9. Viguier M, Pinquier L, Cavelier-Balloy B, De la Salmonière P, CordolianiF, Flageul B et al., Clinical and histopathologic features and immunologicvariables in patients with severe chilblains: a study of therelationship to lupus erythematosus, Medicine 2001; 80(3):180-8. doi:

  10. 10.1097/00005792-200105000-00004.10. Guadagni M y Nazzari G, Acute perniosis in elderly people: a predictivesign of systemic disease?, Acta Derm Venereol 2010; 90(5):545-6.Disponible en: https://doi.org/10.2340/00015555-0918.

  11. Molaee H, Emadi SN, M’Imunya JMN, Davoudi-Monfared E, MohammedA y Razavi Z, Chilblain or perniosis-like skin lesions in childrenduring the covid-19 pandemic: a systematic review of articles, DermatolTher 2022; 35(3):e15298. Disponible en: https://doi.org/10.1111/dth.15298.

  12. Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, ChiaveriniC et al., Clinical, laboratory, and interferon-alpha response characteristicsof patients with chilblain-like lesions during the covid-19pandemic, jama Dermatol 2021; 157(2):202-6. Disponible en: https://doi.org/10.1001/jamadermatol.2020.4324.

  13. Yang X, Pérez OA y English JC, Adult perniosis and cryoglobulinemia:a retrospective study and review of the literature, J Am AcadDermatol 2010; 62(6):e21-2. Disponible en: https://doi.org/10.1016/j.jaad.2009.10.030.

  14. Cappel JA y Wetter D, Clinical characteristics, etiologic associations,laboratory findings, treatment, and proposal of diagnostic criteria ofpernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to2011, Mayo Clin Proc 2014; 89(2):207-15. Disponible en: https://doi.org/10.1016/j.mayocp.2013.09.020.

  15. Boada A, Bielsa I, Fernández-Figueras MT y Ferrándiz C, Perniosis: clinicaland histopathological analysis, Am J of Dermatopathol 2010; 32(1):19-23. Disponible en: https://doi.org/10.1097/DAD.0b013e3181af1d24.

  16. Cribier B, Djeridi N, Peltre B y Grosshans E, A histologic and immunohistochemicalstudy of chilblains, J Am Acad Dermatol 2001; 45(6):924-9. Disponible en: https://doi.org/10.1067/mjd.2001.117861.

  17. Al-Sudany NK, Treatment of primary perniosis with oral pentoxifylline:a double-blind placebo-controlled randomized therapeutictrial, Dermatol Ther 2016; 29(4):263-8. Disponible en: https://doi.org/10.1111/dth.12350.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2022;20